• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
TechNeuralink

A major medical ethics group just asked the FDA to disqualify data from Elon Musk’s Neuralink animal experiments: ‘We want the FDA to proactively launch an investigation’

Prarthana Prakash
By
Prarthana Prakash
Prarthana Prakash
Europe Business News Reporter
Down Arrow Button Icon
Prarthana Prakash
By
Prarthana Prakash
Prarthana Prakash
Europe Business News Reporter
Down Arrow Button Icon
December 13, 2022, 2:56 PM ET
Elon Musk
In November, Elon Musk said that implants on human brains were roughly six months away.CARINA JOHANSEN—NTB/AFP/Getty Images

Elon Musk has several different businesses, from making electric cars at Tesla to building rocket ships at SpaceX. But one of his lesser-known businesses has been in the spotlight lately over accusations that it needlessly killed about 1,500 animals. 

Neuralink, Musk’s brain technology startup, has come under fire recently for its animal testing practices, and the company is being investigated for violations of animal welfare. Over 20 current and former employees claim that the tests were being conducted hastily, and that workers were under pressure from Musk to expedite trials, leading to botched experiments and excessive animal deaths.   

Now, a major medical ethics advocacy group, the Physicians Committee for Responsible Medicine, has requested the Food and Drug Administration hold Neuralink accountable for violating protocols on biological tests, and disqualify the data obtained from animal testing, the Washington Post reported Tuesday. It has also asked the FDA to ban additional animal tests by Neuralink.

“Between what we’ve seen in public records and what has been reported, it’s hard to imagine that Neuralink’s animal experiments meet FDA’s requirements,” Deborah Dubow Press, associate general counsel with the Physicians Committee, said in a statement.

In an interview with Fortune, Ryan Merkley, director of research advocacy for the organization, said that it was concerned that the documents Neuralink was providing to the FDA were not “trustworthy.”

“We want FDA to take a very close look at whatever Neuralink is providing, and ideally, we want the FDA to proactively launch an investigation because it’s clear that over the years from public records and whistleblower reports that Neuralink has not followed its own internal protocols.”

Neuralink did not reply to Fortune’srequest for comment.

If the FDA does dismiss the results collected thus far, it could threaten Neuralink’s business plans for its brain implants and the company’s stated vision of creating a “brain-computer interface.” At a Neuralink event in November, Musk said that implants on human brains were roughly six months away and that the company had already submitted its request to the FDA. He presented a video of a monkey named Pager playing “monkey mind pong,” which resembles ping-pong but he plays it in his mind. Musk claimed that Pager would not be able to do so without using a brain implant, which he described as “replacing a piece of the skull with a smartwatch.”

“Before we would even think of putting a device in an animal, we do everything we possibly can with rigorous benchtop testing, so we are not cavalier,” Musk said during the presentation. He also said that whenever a device was implanted into a sheep, pig, or monkey, it was done to confirm their testing results rather than to explore the outcomes of the experiment on the animal.

The Physicians Committee for Responsible Medicine based its request to the FDA on 700 pages’ worth of documents that were obtained after suing the California National Primate Research Center at the University of California–Davis, which was tasked with conducting the Neuralink animal experiments. The tests were conducted on rhesus macaques, a pink-faced species of monkey originating in Asia, the Washington Post reported.  

Our new weekly Impact Report newsletter examines how ESG news and trends are shaping the roles and responsibilities of today's executives. Subscribe here.

About the Author
Prarthana Prakash
By Prarthana PrakashEurope Business News Reporter
LinkedIn icon

Prarthana Prakash was a Europe business reporter at Fortune.

See full bioRight Arrow Button Icon

Latest in Tech

InvestingStock
There have been head fakes before, but this time may be different as the latest stock rotation out of AI is just getting started, analysts say
By Jason MaDecember 13, 2025
2 hours ago
Politicsdavid sacks
Can there be competency without conflict in Washington?
By Alyson ShontellDecember 13, 2025
3 hours ago
InnovationRobots
Even in Silicon Valley, skepticism looms over robots, while ‘China has certainly a lot more momentum on humanoids’
By Matt O'Brien and The Associated PressDecember 13, 2025
5 hours ago
Sarandos
Arts & EntertainmentM&A
It’s a sequel, it’s a remake, it’s a reboot: Lawyers grow wistful for old corporate rumbles as Paramount, Netflix fight for Warner
By Nick LichtenbergDecember 13, 2025
9 hours ago
Oracle chairman of the board and chief technology officer Larry Ellison delivers a keynote address during the 2019 Oracle OpenWorld on September 16, 2019 in San Francisco, California.
AIOracle
Oracle’s collapsing stock shows the AI boom is running into two hard limits: physics and debt markets
By Eva RoytburgDecember 13, 2025
10 hours ago
robots
InnovationRobots
‘The question is really just how long it will take’: Over 2,000 gather at Humanoids Summit to meet the robots who may take their jobs someday
By Matt O'Brien and The Associated PressDecember 12, 2025
23 hours ago

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Economy
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
22 hours ago
placeholder alt text
Economy
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple CEO Tim Cook out-earns the average American’s salary in just 7 hours—to put that into context, he could buy a new $439,000 home in just 2 days
By Emma BurleighDecember 12, 2025
1 day ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.